Search by Drug Name or NDC
NDC 61919-0166-60 BUSPIRONE HYDROCHLORIDE 5 mg/1 Details
BUSPIRONE HYDROCHLORIDE 5 mg/1
BUSPIRONE HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is BUSPIRONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. Buspirone is in a class of medications called anxiolytics. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 61919-0166-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Buspirone
Product Information
| NDC | 61919-0166 |
|---|---|
| Product ID | 61919-166_0e87fe20-49d1-0435-e063-6294a90a298d |
| Associated GPIs | 57200005100310 |
| GCN Sequence Number | 003782 |
| GCN Sequence Number Description | buspirone HCl TABLET 5 MG ORAL |
| HIC3 | H2F |
| HIC3 Description | ANTI-ANXIETY DRUGS |
| GCN | 28890 |
| HICL Sequence Number | 001620 |
| HICL Sequence Number Description | BUSPIRONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | BUSPIRONE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BUSPIRONE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUSPIRONE HYDROCHLORIDE |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202557 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 61919-0166-60 (61919016660)
| NDC Package Code | 61919-166-60 |
|---|---|
| Billing NDC | 61919016660 |
| Package | 60 TABLET in 1 BOTTLE (61919-166-60) |
| Marketing Start Date | 2019-07-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |